Signaturefd, LLC Geron Corp Transaction History

Signaturefd, LLC

$5.8 Billion
Q3 2025

A detailed history of Signaturefd, LLC transactions in Geron Corp stock. As of the latest transaction made, Signaturefd, LLC holds 14,254 shares of GERN stock, worth $15,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,254

Previous 12,214 16.7%

Holding current value

$15,964

Previous $17,000 11.76%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	BUY	$1.1 - $1.47 $2,244 - $2,998	2,040 Added 16.7%	14,254 $19,000
Q2 2025 Jul 16, 2025	BUY	$1.18 - $1.62 $2,421 - $3,324	2,052 Added 20.19%	12,214 $17,000
Q1 2025 May 01, 2025	BUY	$1.59 - $3.6 $9,306 - $21,070	5,853 Added 135.83%	10,162 $16,000
Q4 2024 Feb 10, 2025	SELL	$3.3 - $4.44 $102 - $137	-31 Reduced 0.71%	4,309 $15,000
Q3 2024 Oct 21, 2024	SELL	$4.17 - $4.99 $1,121 - $1,342	-269 Reduced 5.84%	4,340 $19,000

Q1 2024 May 03, 2024	SELL	$1.75 - $3.44 $5,080 - $9,986	-2,903 Reduced 38.64%	4,609 $15,000
Q4 2023 Jan 31, 2024	BUY	$1.74 - $2.31 $4,706 - $6,248	2,705 Added 56.27%	7,512 $15,000
Q2 2023 Aug 01, 2023	SELL	$1.97 - $3.69 $1,134 - $2,125	-576 Reduced 10.7%	4,807 $15,000
Q4 2022 Jan 27, 2023	SELL	$2.03 - $2.42 $1,213 - $1,447	-598 Reduced 10.0%	5,383 $13,000
Q3 2022 Nov 08, 2022	BUY	$1.67 - $2.94 $998 - $1,758	598 Added 11.11%	5,981 $14,000
Q2 2022 Aug 10, 2022	BUY	$1.19 - $1.65 $1,286 - $1,783	1,081 Added 25.13%	5,383 $8,000
Q1 2022 May 02, 2022	BUY	$0.99 - $1.6 $1,603 - $2,592	1,620 Added 60.4%	4,302 $6,000
Q4 2021 Jan 25, 2022	BUY	$1.22 - $1.72 $1,413 - $1,993	1,159 Added 76.1%	2,682 $3,000
Q3 2021 Oct 28, 2021	BUY	$1.2 - $1.5 $1,078 - $1,348	899 Added 144.07%	1,523 $2,000
Q2 2021 Jul 26, 2021	BUY	$1.25 - $1.83 $780 - $1,141	624 New	624 $1,000

Others Institutions Holding GERN

# of Institutions

287

Shares Held

502M

Call Options Held

643K

Put Options Held

276K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $423M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account